059-9 Wyo. Code R. § 9-5

Current through April 27, 2019

Section 9-5 - Patient Counseling

(a) Upon receipt of a prescription and following a review of the patient's record, a pharmacist or a pharmacy intern shall personally offer to discuss matters which will enhance or optimize drug therapy with each patient or caregiver of the patient. Non-resident pharmacies/pharmacists are not exempt from this regulation Such elements may include the following:

(i) Name and description of the drug;

(ii) Dosage form, dose, route of administration, and duration of drug therapy;

(iii) Intended use of the drug and expected action;

(iv) Special directions and precautions for preparation, administration, and use by the patient;

(v) Common severe side or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the actions required if they occur;

(vi) Techniques for self-monitoring drug therapy;

(vii) Proper storage;

(viii) Prescription refill information;

(ix) Action to be taken in the event of a missed dose; and

(x) Comments relevant to the individual's drug therapy, including any other information peculiar to the specific patient or drug or refusal of counseling.

(b) A pharmacist shall not be required to counsel a patient or caregiver when the patient or caregiver refuses consultation. Every refusal shall be documented by the pharmacist.

(c) Information obtained may be recorded in the patient's manual or electronic profile, in the prescription signature log or in any other system of records and may be considered by the pharmacist in the exercise of professional judgment concerning both the offer to counsel and content of counseling. The absence of any record of a failure to accept the offer to counsel shall be presumed to signify that the offer was accepted and that counseling was provided.

059-9 Wyo. Code R. § 9-5